Public Health Outcomes May Differ After Switching from Brand-Name to Generic Angiotensin II Receptor Blockers

Leclerc, Jacinthe; Blais, Claudia; Rochette, Louis; Hamel, Denis; Guénette, Line; Beaudoin, Claudia; Poirier, Paul
Drugs in R&D
avril, 2020
10.1007/s40268-020-00307-2